PROCR and COVID-19: Finally, deficient EPCR signaling, a key brake element in the coagulation pathway, likely also contributes to the high incidence of thrombotic complications observed in serious COVID-19 cases, including widespread microthrombi, pulmonary embolism, stroke and disseminated intravascular coagulation (12, 78, 79).